Literature DB >> 21494516

The evaluation and management of electrical storm.

Michael Eifling1, Mehdi Razavi, Ali Massumi.   

Abstract

Electrical storm is an increasingly common and life-threatening syndrome that is defined by 3 or more sustained episodes of ventricular tachycardia, ventricular fibrillation, or appropriate shocks from an implantable cardioverter-defibrillator within 24 hours. The clinical presentation can be dramatic. Electrical storm can manifest itself during acute myocardial infarction and in patients who have structural heart disease, an implantable cardioverter-defibrillator, or an inherited arrhythmic syndrome. The presence or absence of structural heart disease and the electrocardiographic morphology of the presenting arrhythmia can provide important diagnostic clues into the mechanism of electrical storm. Electrical storm typically has a poor outcome.The effective management of electrical storm requires an understanding of arrhythmia mechanisms, therapeutic options, device programming, and indications for radiofrequency catheter ablation. Initial management involves determining and correcting the underlying ischemia, electrolyte imbalances, or other causative factors. Amiodarone and β-blockers, especially propranolol, effectively resolve arrhythmias in most patients. Nonpharmacologic treatment, including radiofrequency ablation, can control electrical storm in drug-refractory patients. Patients who have implantable cardioverter-defibrillators can present with multiple shocks and may require drug therapy and device reprogramming. After the acute phase of electrical storm, the treatment focus should shift toward maximizing heart-failure therapy, performing revascularization, and preventing subsequent ventricular arrhythmias. Herein, we present an organized approach for effectively evaluating and managing electrical storm.

Entities:  

Keywords:  Anti-arrhythmiaagents/therapeutic use; cardiomyopathies/complications; catheter ablation; death, sudden, cardiac/prevention & control; defibrillators, implantable/adverse effects; electrocardiogra-phy; heart arrest/etiology/therapy; myocardial infarction/complications; risk factors; tachycardia, ventricular/complications/drug therapy/physiopathology/therapy; ventricular fibrillation/complications/diagnosis/drug therapy/physiopathology/therapy

Mesh:

Substances:

Year:  2011        PMID: 21494516      PMCID: PMC3066819     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  75 in total

Review 1.  Clinical practice. Long-QT syndrome.

Authors:  Dan M Roden
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

Review 2.  Acute and chronic effects of amiodarone on mammalian ventricular cells.

Authors:  I Kodama; K Kamiya; H Honjo; J Toyama
Journal:  Jpn Heart J       Date:  1996-09

3.  Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold.

Authors:  J L Anderson; H E Rodier; L S Green
Journal:  Am J Cardiol       Date:  1983-04       Impact factor: 2.778

4.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

5.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Authors:  A Pacifico; S H Hohnloser; J H Williams; B Tao; S Saksena; P D Henry; E N Prystowsky
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

6.  Rhythm changes during resuscitation from ventricular fibrillation in relation to delay until defibrillation, number of shocks delivered and survival.

Authors:  J Herlitz; A Bång; M Holmberg; A Axelsson; J Lindkvist; S Holmberg
Journal:  Resuscitation       Date:  1997-02       Impact factor: 5.262

7.  Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Authors:  Paul Dorian; Martin Borggrefe; Hussein R Al-Khalidi; Stefan H Hohnloser; Jose M Brum; Daljit S Tatla; Johannes Brachmann; Robert J Myerburg; David S Cannom; Michael van der Laan; Michael J Holroyde; Igor Singer; Craig M Pratt
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

Review 8.  Efficacy of quinidine in high-risk patients with Brugada syndrome.

Authors:  Bernard Belhassen; Aharon Glick; Sami Viskin
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

9.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

Authors:  Bruce L Wilkoff; Brian D Williamson; Richard S Stern; Stephen L Moore; Fei Lu; Sung W Lee; Ulrika M Birgersdotter-Green; Mark S Wathen; Isabelle C Van Gelder; Brooke M Heubner; Mark L Brown; Keith K Holloman
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

10.  Studies on left ventricular function during sustained ventricular tachycardia.

Authors:  S Saksena; J M Ciccone; W Craelius; D Pantopoulos; S T Rothbart; R Werres
Journal:  J Am Coll Cardiol       Date:  1984-09       Impact factor: 24.094

View more
  25 in total

Review 1.  Electrical Storm: Incidence, Prognosis and Therapy.

Authors:  Antonio Sagone
Journal:  J Atr Fibrillation       Date:  2015-12-31

2.  Non benign neonatal arrhythmias observed in a tertiary neonatal intensive care unit.

Authors:  Ahmet Afşin Kundak; Dilek Dilli; Belma Karagöl; Nilgün Karadağ; Ayşegül Zenciroğlu; Nurullah Okumuş; Vehbi Doğan; Nuran Uzunalıç
Journal:  Indian J Pediatr       Date:  2012-10-04       Impact factor: 1.967

3.  Loperamide-Induced Ventricular Tachycardia Storm.

Authors:  William Giesing; Cameron Koester; Mohammad Al-Akchar; Abhishek Kulkarni; Mohamed Labedi
Journal:  Avicenna J Med       Date:  2022-06-22

4.  Continuous Thoracic Paravertebral Block to Treat Electrical Storm.

Authors:  Daryl I Smith; Sarah A Kralovic; Rafeek A Hegazy; Hai Tran
Journal:  Tex Heart Inst J       Date:  2022-03-01

5.  Refractory Electrical Storm in the Absence of Structural Ischemic Heart Disease.

Authors:  Kashmala Khan; Francis Dimtri; Carlos Vargas; Christel Cuevas; Thomas Alexander
Journal:  Cureus       Date:  2020-02-05

6.  First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration.

Authors:  Kevin M Boehm; Daniel C Keyes; Laura E Mader; J Michelle Moccia
Journal:  West J Emerg Med       Date:  2016-10-20

7.  Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series.

Authors:  Mislav Puljević; Vedran Velagić; Davor Puljević; Davor Miličić
Journal:  Croat Med J       Date:  2014-02       Impact factor: 1.351

8.  Electrical storm: Role of stellate ganglion blockade and anesthetic implications of left cardiac sympathetic denervation.

Authors:  Shrinivas Gadhinglajkar; Rupa Sreedhar; M Unnikrishnan; Narayanan Namboodiri
Journal:  Indian J Anaesth       Date:  2013-07

9.  Successful treatment of cardiac electrical storm in dilated cardiomyopathy using esmolol: A case report.

Authors:  L I Li; Yuan-Li Zhou; Xue-Jing Zhang; Hua-Ting Wang
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

10.  Thoracic Epidural Anesthesia Can Be Effective for the Short-Term Management of Ventricular Tachycardia Storm.

Authors:  Duc H Do; Jason Bradfield; Olujimi A Ajijola; Marmar Vaseghi; John Le; Siamak Rahman; Aman Mahajan; Akihiko Nogami; Noel G Boyle; Kalyanam Shivkumar
Journal:  J Am Heart Assoc       Date:  2017-10-27       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.